Are Value-Based Contracts the Answer to Ultra-High-Priced Gene Therapies? | AMCP 2024
Last month, the FDA approved a gene therapy that will have the highest ever price for a new treatment: $4.25 million. Lenmeldy (atidarsagene autotemcel) is a one-time treatment and the first approved gene therapy to treat children with juvenile …